Kiniksa Pharmaceuticals to Present at 39th Annual J.P. Morgan Healthcare Conference
January 04 2021 - 4:19PM
Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that
it will present at the 39th Annual J.P. Morgan
Healthcare Conference on Monday, January 11, 2021 at 4:30
p.m. Eastern Time.
A live webcast of Kiniksa’s presentation will be accessible
through the Investors & Media section of the company’s website
at www.kiniksa.com. A replay of the webcast will be available on
Kiniksa’s website for 14 days following the conference.
About KiniksaKiniksa is a biopharmaceutical
company focused on discovering, acquiring, developing and
commercializing therapeutic medicines for patients suffering from
debilitating diseases with significant unmet medical need.
Kiniksa’s product candidates, rilonacept, mavrilimumab, vixarelimab
and KPL-404, are based on strong biologic rationale or validated
mechanisms, target underserved conditions and offer the potential
for differentiation. These pipeline assets are designed to modulate
immunological pathways across a spectrum of diseases. For more
information, please visit www.kiniksa.com.
Every Second
Counts!™Kiniksa Investor and Media
ContactMark Ragosa(781) 430-8289mragosa@kiniksa.com |
Kiniksa Pharmaceuticals (NASDAQ:KNSA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kiniksa Pharmaceuticals (NASDAQ:KNSA)
Historical Stock Chart
From Apr 2023 to Apr 2024